The acquisition price for one of its immediate peers suggests Cynapsus Therapeutics (TSXV:CT... Read More
Recent news that Halifax-based Immunovaccine (TSXV:IMV) was pulling its proposed public financing du... Read More
Sign up for our newsletter to get timely Canadian stock picks from expert financial analysts.
Share
